MIRA
INFORM REPORT
|
Report Date : |
19.05.2007 |
IDENTIFICATION DETAILS
|
Name : |
DAWA LIMITED |
|
|
|
|
Registered Office : |
Baba |
|
|
|
|
Country : |
|
|
|
|
|
Date of Incorporation : |
1977 |
|
|
|
|
Legal Form : |
Private Limited Liability Company |
|
|
|
|
Line of Business : |
Manufacturers and marketers of quality human and veterinary pharmaceuticals and surgical. |
RATING & COMMENTS
|
MIRA’s Rating : |
Ba |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
Maximum Credit Limit : |
K Shs 5,000,000 |
|
|
|
|
Status : |
Satisfactory |
|
|
|
|
Payment Behaviour : |
Regular |
|
|
|
|
Litigation : |
Clear |
COmpany NAME
DAWA LIMITED (Correct)
DAWA LTD PHARMACEUTICALS
MFG OF HUMAN & VETERINARY MEDICINES (Requested)
ADDRESS
Street :
Area :
P.O. Box :
16633
Town :
Country :
Telephone :
(254 20) 856 1554 / 856 3093 / 856 3405
Fax : (254 20) 856 2283 / 856 1550
E-Mail : admin@dawalimited.com
Formerly Known As
Dawa Pharmaceuticals Ltd
SENIOR COMPANY
PERSONNEL
Name Position
1. Raju Mohendra Managing
Director
2. A.J. Patel General Manager
3. Sohim Shah Financial Director
Total Employees
160
PAYMENTS
No complaints have been
heard regarding payments from local suppliers or banks.
Subject is a well
established company operating since 1977 and was acquired by current
shareholders in 2004.
We consider it is
acceptable to deal with subject for SMALL amounts, although it is normal
acceptable practice for international suppliers to deal on secured terms with
Kenyan importers.
Opinion on maximum credit
: K Shs 5,000,000
Trade risk assessment :
PRINCIPAL BANKERS
NAME :
INVESTMENTS AND MORTGAGES BANK LTD
Branch :
I&
Street :
2nd
PO Box :
30238 - 00100
Town :
Telephone : (254 20) 271 1994-8 / 310105-7
Fax :
(254 20) 271 3757 / 271 6372
FINANCIAL INFORMATION
Private companies in
Sales Turnover : K Shs 222,500,000 - 2006 - exact
Net Profit : K Shs 13,000,000 - 2006 - exact
Financial year ends 31
December.
LEGAL STATUS AND
HISTORY
Date Started : 1977
History : The company was
established in 1977 as a Limited Liability Company under the name Dawa
Pharmaceuticals Ltd with KRKA (
Authorised & Paid up
Capital : 1000 ordinary shares at 100 each
Private Limited Liability
Company with the following shareholders :
Name Percentage
1. Raju Mohendra 50%
(
2. A.J. Patel 50%
(
Affiliated companies of
Dawa Limited :
Associates
1. Medisel Kenya Limited
P.O. Box : 540
Thika
Telephone: (254 151) 30378 / 30379 / 22230
Fax
: (254 151) 22230
E-Mail
: medisel@africaonline.co.ke
2. Sidapharm
Ath. Stageriti 21
P.O. Box : 54352
Tel
: (30 2310) 945 899
Fax
: (30 2310) 989 846
E-Mail : shelleye@hotmail.gr
ACTIVITIES
The Company is involved
in the following activities :
Manufacturers and
marketers of quality human and veterinary pharmaceuticals and surgical.
Imports worldwide.
Exports to almost all the
countries in the Comesa region and
FACILITIES
The Company has the
following facilities :
Premises comprising
administrative offices, factory and storage facilities located at the heading
address.
SPECIAL NOTE
You enquired on : DAWA
LTD PHARMACEUTICALS MFG OF HUMAN & VETERINARY MEDICINES.
Please note the correct
name is as per heading.
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest capability
for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Unfavourable & favourable factors carry similar weight in credit
consideration. Capability to overcome financial difficulties seems comparatively
below average/normal. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
NR |
In view of the lack of information, we have no basis upon which to
recommend credit dealings |
No Rating |
|
This score serves as a reference to assess SC’s credit risk
and to set the amount of credit to be extended. It is calculated from a
composite of weighted scores obtained from each of the major sections of this
report. The assessed factors and their relative weights (as indicated through
%) are as follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)